| answer text |
<p>The Government has decided not to procure Evusheld at this present time for prevention
through emergency routes at this time. This is a decision based on independent clinical
advice by the multi-agency RAPID C-19 and a national expert policy working group.
These groups considered a range of evidence, including clinical trial data, in vitro
analysis and emerging observational studies and concluded that there is currently
insufficient evidence of benefit to recommend deployment. The Chief Medical Officer
for England is content that the correct process for providing clinical advice has
been followed and agrees that this should now be referred to the National Institute
for Health and Care Excellence for further evaluation.</p><p>The Department wrote
to patient groups on 5 September 2022 with information on this decision and evidence
considered and intends to publish further details of the clinical advice received
shortly.</p>
|
 |
